International study identifies promising therapy to prevent relapses in rare neurological disease
August 06, 2026
August 06, 2026
ROCHESTER, Minnesota, Aug. 6 [Category: BizHospital] -- The Mayo Clinic issued the following news release:
* * *
International study identifies promising therapy to prevent relapses in rare neurological disease
*
ROCHESTER, Minn. -An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in myelin oligodendrocyte glycoprotein antibody-associated dise . . .
* * *
International study identifies promising therapy to prevent relapses in rare neurological disease
*
ROCHESTER, Minn. -An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in myelin oligodendrocyte glycoprotein antibody-associated dise . . .